<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药合作投融资联盟 | wechat-feeds</title><link>http://MzU2NTc4MzYyOA.favicon.privacyhide.com/favicon.ico</link><description>医药行业</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 06 May 2021 10:10:28 +0800</pubDate><image><url>http://MzU2NTc4MzYyOA.favicon.privacyhide.com/favicon.ico</url><title>医药合作投融资联盟 | wechat-feeds</title><link>http://MzU2NTc4MzYyOA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>中美冠科收购OcellO B.V.以扩大其临床前体外药物开发服务范围</title><link>https://mp.weixin.qq.com/s/s9fdJPyDTMVqV9imGk4tLQ</link><description></description><content:encoded><![CDATA[中美冠科收购OcellO B.V.以扩大其临床前体外药物开发服务范围]]></content:encoded><pubDate>Thu, 06 May 2021 09:08:57 +0800</pubDate></item><item><title>新锐|种子轮700万美元融资，加速AAV载体生产</title><link>https://mp.weixin.qq.com/s/PjuV6X_Bafpv9YeHifAtnA</link><description></description><content:encoded><![CDATA[新锐|种子轮700万美元融资，加速AAV载体生产]]></content:encoded><pubDate>Thu, 06 May 2021 09:08:57 +0800</pubDate></item><item><title>细胞疗法自动化生产平台B轮融资8200万美元，德诚资本领投</title><link>https://mp.weixin.qq.com/s/NtcNi7slXqfHIN7l6kX_xQ</link><description></description><content:encoded><![CDATA[细胞疗法自动化生产平台B轮融资8200万美元，德诚资本领投]]></content:encoded><pubDate>Thu, 06 May 2021 09:08:57 +0800</pubDate></item><item><title>重磅！萌蒂制药中国业务拟超10亿美元出售？</title><link>https://mp.weixin.qq.com/s/uLVri8vEHXMUF3SjjkRIrw</link><description></description><content:encoded><![CDATA[重磅！萌蒂制药中国业务拟超10亿美元出售？]]></content:encoded><pubDate>Thu, 06 May 2021 09:08:57 +0800</pubDate></item><item><title>德晋医疗完成数亿美元B轮融资</title><link>https://mp.weixin.qq.com/s/72eSRcVtMdfUfC26p7WzKQ</link><description></description><content:encoded><![CDATA[德晋医疗完成数亿美元B轮融资]]></content:encoded><pubDate>Thu, 06 May 2021 09:08:57 +0800</pubDate></item><item><title>Athenex宣布1.85亿美元收购CAR-NKT平台公司</title><link>https://mp.weixin.qq.com/s/40UW77LeQIxpdALtc-vf9A</link><description></description><content:encoded><![CDATA[Athenex宣布1.85亿美元收购CAR-NKT平台公司]]></content:encoded><pubDate>Thu, 06 May 2021 09:08:57 +0800</pubDate></item><item><title>Roivant Sciences达成SPAC合并交易，估值达到73亿美元</title><link>https://mp.weixin.qq.com/s/XlKtAqkjQRUHPd73EfakaA</link><description></description><content:encoded><![CDATA[Roivant Sciences达成SPAC合并交易，估值达到73亿美元]]></content:encoded><pubDate>Tue, 04 May 2021 08:29:36 +0800</pubDate></item><item><title>新锐|基因疗法Affinia Therapeutics完成1.1亿美元B轮融资</title><link>https://mp.weixin.qq.com/s/RcgLJ5nFqH1Uxbom6vb9IQ</link><description></description><content:encoded><![CDATA[新锐|基因疗法Affinia Therapeutics完成1.1亿美元B轮融资]]></content:encoded><pubDate>Tue, 04 May 2021 08:29:36 +0800</pubDate></item><item><title>Adcendo完成6200万美元A轮融资，开发新型ADC药物</title><link>https://mp.weixin.qq.com/s/WDzUJ0Jcc6XOaJq-I0w93g</link><description></description><content:encoded><![CDATA[Adcendo完成6200万美元A轮融资，开发新型ADC药物]]></content:encoded><pubDate>Thu, 29 Apr 2021 16:13:15 +0800</pubDate></item><item><title>Adcentrx完成5000万美元A轮融资，开发新型ADC药物</title><link>https://mp.weixin.qq.com/s/k9DTCknUAGjlyUGZnU6ItA</link><description></description><content:encoded><![CDATA[Adcentrx完成5000万美元A轮融资，开发新型ADC药物]]></content:encoded><pubDate>Thu, 29 Apr 2021 16:13:15 +0800</pubDate></item><item><title>辉瑞收购Amplyx制药，获得II期临床抗真菌新药</title><link>https://mp.weixin.qq.com/s/IYTovtENP95q0DN1NdZAYw</link><description></description><content:encoded><![CDATA[辉瑞收购Amplyx制药，获得II期临床抗真菌新药]]></content:encoded><pubDate>Thu, 29 Apr 2021 15:07:13 +0800</pubDate></item><item><title>新锐|放射治疗和诊断公司完成1100万美元A轮融资</title><link>https://mp.weixin.qq.com/s/FpXWzvvgIskzrg-lv81u4A</link><description></description><content:encoded><![CDATA[新锐|放射治疗和诊断公司完成1100万美元A轮融资]]></content:encoded><pubDate>Thu, 29 Apr 2021 15:07:13 +0800</pubDate></item><item><title>新锐|Boundless Bio完成1.05亿美元B轮融资</title><link>https://mp.weixin.qq.com/s/j_XndbXl89RJ4YXGAFdZhg</link><description></description><content:encoded><![CDATA[新锐|Boundless Bio完成1.05亿美元B轮融资]]></content:encoded><pubDate>Thu, 29 Apr 2021 15:07:13 +0800</pubDate></item><item><title>Caresyntax完成1亿美元C轮融资，使手术更智能，更安全</title><link>https://mp.weixin.qq.com/s/CSjqTnDMXr7eR4QdVFNp2w</link><description></description><content:encoded><![CDATA[Caresyntax完成1亿美元C轮融资，使手术更智能，更安全]]></content:encoded><pubDate>Thu, 29 Apr 2021 15:07:13 +0800</pubDate></item><item><title>ReAlta Life Sciences完成2000万美元A3轮融资</title><link>https://mp.weixin.qq.com/s/JtyenN8zm46CC6bvXfjWuQ</link><description></description><content:encoded><![CDATA[ReAlta Life Sciences完成2000万美元A3轮融资]]></content:encoded><pubDate>Thu, 29 Apr 2021 15:07:13 +0800</pubDate></item><item><title>安进公布明星KRAS抑制剂商品名：Lumakras</title><link>https://mp.weixin.qq.com/s/milj08I4JpDD7fP4xRrUdg</link><description></description><content:encoded><![CDATA[安进公布明星KRAS抑制剂商品名：Lumakras]]></content:encoded><pubDate>Thu, 29 Apr 2021 15:07:13 +0800</pubDate></item><item><title>Arch Oncology完成1.05亿美元C轮融资</title><link>https://mp.weixin.qq.com/s/31Q0Ok4s729YpNGJOqdnjQ</link><description></description><content:encoded><![CDATA[Arch Oncology完成1.05亿美元C轮融资]]></content:encoded><pubDate>Wed, 28 Apr 2021 10:54:41 +0800</pubDate></item><item><title>新锐|下一代ADC公司完成近500万美元种子轮融资</title><link>https://mp.weixin.qq.com/s/Mcf_kJq362MqO1JpW5bVxQ</link><description></description><content:encoded><![CDATA[新锐|下一代ADC公司完成近500万美元种子轮融资]]></content:encoded><pubDate>Wed, 28 Apr 2021 10:54:41 +0800</pubDate></item><item><title>AI新药|Exscientia宣布完成2.25亿美元D轮融资，可额外获得3亿美元</title><link>https://mp.weixin.qq.com/s/r4h8k7CMZ0Tw2sP86FVvFg</link><description></description><content:encoded><![CDATA[AI新药|Exscientia宣布完成2.25亿美元D轮融资，可额外获得3亿美元]]></content:encoded><pubDate>Wed, 28 Apr 2021 10:54:41 +0800</pubDate></item><item><title>Ultivue完成5000万美元D轮融资</title><link>https://mp.weixin.qq.com/s/m7JneNrHpX_vDHJOnJlidQ</link><description></description><content:encoded><![CDATA[Ultivue完成5000万美元D轮融资]]></content:encoded><pubDate>Wed, 28 Apr 2021 10:54:41 +0800</pubDate></item></channel></rss>